By Josh White
Date: Wednesday 17 Sep 2025
(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday.
| Holding(s) in Company | 03-Nov-2025 | 16:50 | RNS | 
| Total Voting Rights | 03-Nov-2025 | 13:31 | RNS | 
| Holding(s) in Company | 30-Oct-2025 | 16:54 | RNS | 
| Director/PDMR Shareholding | 30-Oct-2025 | 11:48 | RNS | 
| Holding(s) in Company | 29-Oct-2025 | 11:52 | RNS | 
| Questor:Kier Group | 01-Dec-2011 | Telegraph | 
| Investment Column:Kier | 16-Sep-2011 | The Independent | 
| Questor:Kier Group | 24-Jun-2011 | Telegraph | 
| Questor : Kier Group | 25-Nov-2010 | Telegraph | 
| Investment Column:Kier | 23-Nov-2010 | The Independent | 
No recent information was found.
| Currency | UK Pounds | 
| Share Price | 215.50p | 
| Change Today | -1.00p | 
| % Change | -0.46 % | 
| 52 Week High | 231.50p | 
| 52 Week Low | 115.20p | 
| Volume | 1,084,633 | 
| Shares Issued | 445.08m | 
| Market Cap | £959.15m | 
| RiskGrade | 260 | 
| Value | 
		 | 
		
|---|
| Price Trend | 
		 | 
		
|---|
| Income | 
		 | 
		
|---|
| Growth | 
		 | 
		
|---|
| Strong Buy | 5 | 
| Buy | 1 | 
| Neutral | 1 | 
| Sell | 0 | 
| Strong Sell | 0 | 
| Total | 7 | 

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 30-Oct-25 | 24-Apr-25 | 
| Paid | 03-Dec-25 | 02-Jun-25 | 
| Amount | 5.20p | 2.00p | 
| Time | Volume / Share Price | 
| 16:35 | 3,947 @ 215.50p | 
| 16:35 | 269,258 @ 215.50p | 
| 16:35 | 17 @ 215.50p | 
| 16:35 | 4,916 @ 215.50p | 
| 16:35 | 1,781 @ 215.50p | 
| Chair | Matthew Lester | 
| CEO | Stuart Togwell | 
You are here: research